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IL-8 by Venular Endothelial Cells
Imhof and Dunon, 1995). The induction of the integrin-
mediated firm neutrophil adhesion to the ECs requires
rapid activation of b2 integrins. This can be achieved
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Manfred Auer,* Elin Hub,* and Antal Rot*³ by stimulation of leukocytes with chemoattractants, in-
cluding IL-8 (Carveth et al., 1989; Detmers et al., 1990).*Novartis Forschungsinstitut
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is the induction of directed leukocyte migration, i.e.,Austria
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ents of soluble molecules (Rot, 1992a). Therefore, leuko-University of British Columbia
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tants (reviewed by Colditz, 1985; Rot, 1992a). However, it
has been noted that soluble chemoattractant gradients
cannot persist on the blood-EC interface: they are likely
Summary to be washed away by the blood flow (Colditz, 1985;
Rot, 1992c; Tanaka et al., 1993b). Also, soluble chemo-
Chemokines have been convincingly implicated in ac-
attractant gradients would activate leukocytes in cir-
tuating inflammatory leukocyte emigration. To affect
culation before their initial selectin-mediated adhesive
the circulating leukocytes, tissue-derived chemokines
interaction with the ECs. Such activation results in the
have to traverse the endothelial cells (ECs). This was
loss of leukocytes' ability to initiate EC adhesion and
thought to be accomplished by chemokine diffusion
emigrate (Ley et al., 1993). Due to these theoretical con-
through the intercellular gaps. On the contrary, we
siderations, the observation of the in situ IL-8 binding
show by electron microscopy that the prototype
to the ECs in human skin (Rot, 1992b), and the ability
chemokine IL-8 is internalized by venular ECs ablumi-
of the immobilized IL-8 to attract leukocytes in vitro
nally and transcytosed to the luminal surface. Here, it
(Rot, 1993a), it was suggested that IL-8 and other che-
is presented to the adherent leukocytes on the EC
mokines may promote the leukocyte-EC adhesion in
membrane, predominantly in association with the EC vivo more effectively while being immobilized on the EC
projections. The intact C terminus of IL-8, the mole- membrane (Rot, 1992c; Tanaka et al., 1993b). Whereas
cule's ªimmobilizationº domain, is required for the EC this idea has been rapidly accepted and is featured
binding, transcytosis, and consequently, the in vivo
in several comprehensive reviews (Carlos and Harlan,
proemigratory activity of IL-8, indicating that the de-
1994; Springer, 1994; Imhof and Dunon, 1995; Schall
scribed subcellular interactions of IL-8 with the ECs
and Bacon, 1994; Bacon and Schall, 1996; Butcher and
are functionally relevant.
Picker, 1996), the hypothesis has not been formally
proven: neither chemokine immobilization on the luminal
EC membrane nor its presentation to theadherent leuko-
Introduction cytes has been observed experimentally. To study the
subcellular events that underliechemokine-induced leu-
Inflammatory diseases are characterized by the egress kocyte-EC adhesion and emigration, IL-8 and 125I-IL-8
of leukocytes from the circulation across the walls of injections in rabbit skin have been followed by immu-
small blood vessels into the affected tissues. Chemoat- noelectron microscopy (IEM) and electron microscopic
tractants, including the prototype chemokine (chemo- autoradiography (EMA), respectively. These experiments
tactic cytokine) interleukin-8 (IL-8), have conventionally allowed us to address the subcellular fate of IL-8 directly
been thought to drive leukocyte emigration (Baggiolini in the process of leukocyte emigration and lead to the
et al., 1994; Schall, 1994; Strieter et al., 1996). The entire observation of chemokine presentation on the luminal
process of inflammatory neutrophil recruitment can be EC membrane and also to the description of EC trans-
emulated by the injection of IL-8 into the tissues (Colditz cytosis of IL-8 in the abluminal-to-luminal direction.
et al., 1990; Leonard et al., 1991; Swensson et al., 1991).
A prerequisite of neutrophil emigration is their attach-
Results and Discussionment to the EC surface. According to the current para-
digm, this interaction involves a stepwise engagement
EC Surface Presentation of IL-8of juxtaposed neutrophil- and EC-adhesion molecules:
After intradermal injection in rabbits, IL-8 immunoreac-first selectins and their sugar counterligands, which me-
tivity was detected by IEM at all the time points studieddiate neutrophil tethering and rolling, followed by b2
in the walls of postcapillary venules and small veins, butintegrins and immunoglobulin-like intercellular adhesion
not any other blood vessels. This is the segment of themolecules, which mediate firm neutrophil adhesion
circulatory tree in which leukocytes adhere to the ECs(Butcher, 1991; Carlos and Harlan, 1994; Springer, 1994;
and emigrate in clinical and experimental inflammatory
lesions and in response to injections of chemoattrac-
tants (Colditz et al., 1990; Rot, 1992a; Ebnet et al., 1996).³To whom correspondenceshould be addressed, atBrunnerstrasse
59, A-1235, Vienna, Austria. IL-8 bound to the ECs, pericytes, and other perivascular
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Figure 1. IL-8 Binding to the Luminal Surface
of the Venular ECs in Rabbit Skin
(A) IL-8, seen as electron-dense grains, ap-
pears on a microvillous-like extension of the
luminal EC surface (magnification 368,800).
(B) Chemokine presentation by the EC (E) to
an adherent neutrophil (N). IL-8 (arrows) is
concentrated on the tips of EC projections;
in the region of direct cell contact, IL-8 is also
visible on the neutrophil surface (353,680).
cells; IL-8 was also seen in the dermal macrophages (Picker et al., 1991; Berlin et al., 1995; Moore et al., 1995;
Steegmaier et al., 1997). It is possible that microvilli andand in the extracellular matrix, predominantly around
the blood vessels, in part associated with collagen fibers EC projections may represent analogously salient sites,
since, like the leukocyte microvilli, they may preferen-and in part with the ground substance. Already 30 min-
utes after its injection, IL-8 immunoreactivity was ob- tially harbor adhesion molecules, e.g., a counterligand
of L-selectin, sialomucin CD34 (Fina et al., 1990), andserved onthe luminal ECsurface where, at all time points
studied, it was particularly concentrated on the microvil- constitute the initial points of contact between the endo-
thelium and the adherent leukocytes. At the points oflous processes (Figure 1A) and tips of larger projections
that extended into the luminal space (Figure 1B). Ap- such direct neutrophil-EC contact, IL-8 was also associ-
ated with the neutrophil membrane (Figure 1B). Thisproximately ten times more IL-8 immunoreactivity was
present on luminal projections than on the smooth EC embodies the conjectural EC presentation of chemokine
immobilized on the EC surface (Rot, 1992c; Tanaka,membrane, with two out of three observed microvilli
harboring IL-8 (Table 1). Similar preferential distribution 1993b). There are indications that the localization to the
microvilli is of great importance for the in vivo function ofto the tips of leukocyte microvilli has been described
for several adhesion molecules involved in primary adhesion molecules. For example, the L-selectin-CD44
chimera that is excluded from the leukocyte microvilli,juxtacrine interaction with the ECs, e.g., L-selectin,
P-selectin ligand, E-selectin ligand, and a4 integrins despite its ability to initiate EC adhesion under static
EC Transcytosis and Presentation of IL-8
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Table 1. Distribution of IL-8 Immunoreactivity on the EC Surface in Rabbit Venules
Flat Membrane Microvillous Membrane Number of Microvilli
Time Length Number Grains/ Length Number Grains/
Venule (min) (mm) of Grains 10 mm (mm) of Grains 10 mm Immunopositive Immunonegative
1. 30 18.2 4 2.2 53.3 28 5.3 3 3
2. 30 30.5 4 1.3 30.8 17 5.5 5 0
3. 60 36.1 1 0.3 22.2 6 2.7 4 3
4. 60 13.1 0 0 46.8 8 1.7 3 1
5. 60 9.4 0 0 25 38 15.2 5 2
6. 60 45 9 2.0 3.3 14 42.0 2 0
7. 60 19 3 1.6 24.1 11 4.6 2 3
8. 120 30.4 4 1.3 31.1 39 12.5 8 4
9. 120 47.1 2 0.4 34.1 10 2.9 1 2
10. 120 34.7 0 0 62.2 6 1.0 2 2
11. 120 40.3 2 0.5 20 14 7.0 3 0
12. 120 25.1 0 0 22.8 10 4.4 2 0
Mean 6 SEM Ð 29 6 3.6 2.4 6 0.8 0.8 6 0.2 31 6 4.6 16.8 6 3.4 8.7 6 3.2 3.3 6 0.6 1.7 6 0.4
IL-8 was injected into rabbit skin and detected using IEM. The length of cell membrane of microvilli and projections (microvillous membrane)
and of the flat portions was measured using an electronic measuring device (onLine 5, Kasper and Richter, Germany). The distribution of gold
grains on the luminal membrane was assessed in 12 random venules that contained more than 5 luminal grains. The concentration of grains
on microvillous membrane (grains/mm) was significantly higher than on flat portions (p , 0.05 in t-test). Significantly more microvilli harbored
IL-8 than did not (p , 0.05 in t-test).
conditions, fails to tether leukocytes under the condi- and incorporated into smooth membrane-bound plas-
malemmal vesicles measuring 40±70 nm (Figures 3A±tions of lateral shear stress (von Andrian et al., 1995). It
3C) that contained caveolin (Figure 3F), and accumu-is attractive to postulate that the localization of chemo-
lated primarily in basal and apical portions of the ECkines to the EC microvilli,described here, may be equally
cytoplasm. Such vesicles have previously been shownimportant for their successful presentation to the rolling
to increase in number following intradermal injection ofleukocytes and their in vivo proemigratory activity.
IL-8 (Schubert et al., 1989). In addition, IL-8 was con-
tained in larger electron-lucent vesicles of greater thanEC Transcytosis of IL-8
100 nm diameter (Figure 3D). Upon fusion of both typesIn inflammation, ECs fulfill the task of conveying multiple
of vesicles with the apical cell membrane, IL-8 was ob-molecular signals from the tissues to the circulating leu-
served on the luminal surface (Figure 3E). At differentkocytes that lead to their adhesion and emigration. Two
time points after its injection, the subcellular localizationalternative ways of ªinformation transferºby theECs can
of IL-8,quantitative differences aside (Table2), was simi-be envisaged: the direct posting of soluble mediators
lar. No IL-8 was detected at the junctions themselvesderived from the surrounding tissue and the production
or in the luminal clefts between the cells adjacent to theby the ECs of secondary cell surface±expressed and
junctions.soluble effector molecules, including IL-8 (Ebnet et al.,
The localization of IL-8 within the vesicular compart-1996). To show unequivocally that it was the injected
ment of the EC cytoplasm and the time course of itsand not secondary, EC-produced chemokine that we
accumulation on the luminal EC surface (Table 2) ishave observed by IEM on the luminal cell surface, radio-
consistent with the transcytotic route of chemokinelabeled IL-8 was injected into the rabbit skin and its
transport. Plasmalemmal vesicles (caveolae) are knownsubcellular localization was followed by EMA. This
to serve as vehicles of EC transport of several molecules,method yielded similar results to those obtained by IEM
though primarily in capillaries and arteries and in the
(Figure 2), indicating that injected IL-8 rapidly crosses
luminal-to-abluminal direction (Vasile et al., 1983; Ghi-
the vessel wall and appears on the luminal EC surface.
tescu et al., 1986; Milici et al., 1987; Parton et al., 1994;
Likewise, the IL-8 produced by extravascular cells (e.g., Pedrescu et al., 1994, Schnitzer and Oh, 1996). In other
macrophages, fibroblasts, epithelial cells, etc.) to exert polar cells, e.g., epithelial cells, transcytosis is an impor-
its proemigratory effect must traverse the EC barrier. tant mechanism of molecular transport across the cellu-
Theoretically, there are several ways in which this could lar barriers and takes place, with some exceptions, pri-
be achieved: transcellular transport, pericellular diffu- marily in the basal-to-apical direction (Mostov, 1994).
sion between the ECs, or movement in the plane of the Even cells that are strewn in the tissues and do not form
cell membrane. However, it has been generally assumed confluent barriers, e.g., macrophages and osteoclasts,
that chemokines reach the circulation by diffusion transcytose their metabolites rather than allow them to
through the gaps between the ECs (reviewed by Furie diffuse pericellularly (Nesbitt and Horton, 1997; Salo et
and Randolf, 1995; Ebnet et al., 1996). The IEM study al., 1997).
of the IL-8-injected rabbit skin allowed us to observe The exact subcellular sequelae of caveolae-driven EC
the mechanism of chemokine transport. In addition, IL-8 transcytosis are subject to ongoing debate. Two alterna-
was injected in vitro into intact viable human skin that tive, mutually nonexclusive mechanisms of EC trans-
was removed during elective surgery. In both experi- cytosis have been envisaged. The first implies an active
mental systems, we observed that IL-8, following its shuttle-like movement of cargo-loaded vesicles be-
tween the EC surfaces (Ghitescu et al., 1986; Parton etbinding to the abluminal EC surface, was internalized
Cell
388
Molecules Involved in EC Binding
and Transcytosis of IL-8
Because chemokines bind heparin and related glycos-
aminoglycans, it was suggested that heparan sulfate
(HS), which is abundantly present on the EC surface,
immobilizes chemokines (Rot, 1992b, 1993b; Tanaka et
al., 1993a, Webb et al., 1993; Witt and Lander, 1994).
The digestion of frozen sections of IL-8-injected human
skin by heparitinase, an enzyme that specifically hydro-
lyzes HS, reduced the EC-associated IL-8 immunoreac-
tivity, including that on the luminal membrane (Figure 4).
This supports the involvement of HS in IL-8 presentation
and transcytosis by the EC. HS participates in the EC
endocytosis and transcytosis of several other molecules
including transferrin, lipoprotein lipase, and angiogenin
(Omoto et al., 1990; Nakazono et al., 1991; Saxena et
al., 1991; Moroianu and Riordan, 1994). HS molecules
on the luminal EC surface, besides immobilizing chemo-
kines, may play an additional role in the process of
leukocyte emigration since they can contribute to sev-
eral steps of leukocyte-EC adhesion by serving as
counterligands for leukocyte L-selectin, the b2 integrin
Mac-1, and PECAM-1 (DeLisser et al., 1993; Norgard-
Sumnicht et al., 1993; Diamond et al., 1995).
However, HS is not the sole EC molecule with chemo-
kine binding properties; other molecules may contribute
to the EC transcytosis of chemokines. Duffy antigen/
receptor for chemokines (DARC), which was initially de-
scribed on the erythrocyte surface (Darbonne et al.,
1991; Horuk et al., 1993), has recently been found on
the ECs of postcapillary venules (Hadley et al., 1994;
Peiper et al., 1995). It binds members of both a- and
b-chemokine subfamilies, but not MIP-1a (Neote et al.,
1993; Szabo et al., 1995). This chemokine binding profile
Figure 2. Autoradiographic Localization of 125I-IL-8 in Rabbit Skin
is mirrored in situ by the ECs. RANTES, a b-chemokine,
(A) Radiolabel is observedwithin the venular EC (E) andat the luminal
cross-competes with IL-8 for the EC binding (E. H. andsurface (L), as well as in the vessel wall, on the surface of pericytes,
A. R., unpublished data) and localizes to the same sub-and in the endothelial basement membrane (317,420).
cellular EC compartments as IL-8 (Figure 5). In contrast,(B) Adherent neutrophil (N) in close contact with the luminal surface
of an EC (E). 125I-IL-8 is present at the interface between the two we were not able to observe MIP-1a localization to the
cells and has been internalized by the neutrophil (317,420). EC after its intradermal injection, while it has been de-
tected in resident macrophages (Figure 5F). Also, MIP-1a
failed to associate with ECs in the in situ binding assay
al., 1994; Pedrescu et al., 1994; Schnitzer et al., 1996). (E. H. and A. R., unpublished data). Since, akin to other
Recently, it has been shown that caveolae contain the chemokines, MIP-1a binds heparin (Koopmann and
molecular machinery required for budding, movement, Krangel, 1997), it is the ªfingerprintº of DARC's specific-
and docking with the cell membrane (Schnitzer et al., ity that can be recognized in the pattern of chemokine
1995) and that their fission from the cell surface is in- binding by the ECs. Future experiments should decide
duced by the hydrolysis of guanosine triphosphate whether DARC plays a role in chemokine transcytosis
(Schnitzer et al., 1996). An alternative mechanism im- and presentation by the ECs and how DARC and HS
plies that molecules may diffuse passively through the may cooperate in these two functions.
pores that form by fusion of the individual vesicles. In
the microvascular ECs, caveolae were described to fuse IL-8 Immobilization Is Required for Its EC
with each other and with larger vacuoles to form grape- Transcytosis and In Vivo Activity
like conglomerate structures, the vesiculo-vacuolar or- IL-8 has two spatially parted functional domains: the
ganelles, which, according to the three-dimensional re- N terminus, which is required for the elicitation of the
construction studies, can span the EC cytoplasm and leukocyte responses through the G protein±coupled re-
connect luminal and abluminal EC surfaces (Kohn et ceptors (Clark-Lewis et al., 1991), and the C-terminal
al., 1992; Dvorak et al., 1996; Feng et al., 1996). Under a helix, which serves as an ªimmobilizationº domain
different circumstances, either of the two alternative mediating the binding of IL-8 to HS (Webb et al., 1993;
mechanisms of transcytosis or both may take place; our Witt and Lander, 1994) and possibly other molecules.
data do not allow us to judge which one is used for the We used a chemically synthesized, C-terminally trun-
transport of IL-8 from the abluminal to the luminal EC cated IL-8 analog IL-8(1±63) that has retained neutro-
phil-activating characteristics (Clark-Lewis et al., 1991)surface.
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Figure 3. Transcytosis of IL-8 by Venular ECs in Human Skin
(A) IL-8 immunoreactivity at the abluminal surface of the EC. The inset shows the uptake of IL-8 into a plasmalemmal vesicle at the abluminal
EC membrane.
(B and C) IL-8 in plasmalemmal vesicles in apical and basal portions of EC cytoplasm, respectively.
(D) IL-8 in large electron-lucent vesicles and on the cell surface (arrowed).
(E) Appearance of IL-8 on the luminal surface of the endothelium.
(F) Colocalization of IL-8 and caveolin in uncoated plasmalemmal vesicles. IL-8 and caveolin are visualized by 10 nm silver-enhanced gold and 5
nm silver-enhanced gold grains, respectively. Plasmalemmal vesicles that contain IL-8 and caveolin are arrowed. (Magnifications: [A], 363,990;
inset, 3113,400; [B], 3115,830; [C], 391,530; [D], 3102,060; [E], 3103,680; [F], 3122,472.)
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Table 2. Distribution of IL-8 and IL-8(1±63) Immunoreactivity in Venular ECs of Human Skin
Abluminal Surface Intracellular Luminal Surface
Time Chemokine (particles/10 mm) (particles/10 mm2) (particles/10 mm)
0' Uninjected 0.4 6 0.3 1.8 6 0.8 0.4 6 0.2
60' Uninjected 0.6 6 0.3 1.3 6 2.9 0.5 6 0.3
0' IL-8 1.6 6 0.4 3.7 6 1.0 1.1 6 0.5
30' IL-8 1.9 6 0.6 9.8 6 1.4 3.5 6 0.7
60' IL-8 5.8 6 1.5 12.7 6 3.0 4.4 6 1.1
120' IL-8 7.8 6 1.1 23.7 6 3.9 11.7 6 2.0
0' IL-8(1±63) 0.7 6 0.4 4.2 6 0.8 0.8 6 0.3
30' IL-8(1±63) 2.8 6 1.1 5.6 6 2.0 1.0 6 0.5*
60' IL-8(1±63) 1.5 6 0.6* 5.3 6 1.3* 0.2 6 0.1*
120' IL-8(1±63) 2.1 6 0.7* 4.1 6 1.1* 1.0 6 0.4*
Chemokines were injected in human skin and detected using IEM. All values are after subtracting the individual background control values
that were obtained using equimolar normal rabbit immunoglobulin instead of anti-IL-8. Control means were 1.9 6 0.7, 1.5 6 0.4, and 1.4 6
0.6 for abluminal, intracellular, and luminal immunoreactivity, respectively. Asterisks mark IL-8(1±63) values significantly lower than correspond-
ing IL-8 values (p , 0.05 in t-test).
but has impaired heparin binding (Webb et al., 1993) to caveolae but requires binding to the EC membrane via
the C terminus of the chemokine. The functional impor-evaluate the requirement of IL-8 immobilization for its
tance of IL-8 immobilization in the process of in vivosubcellular interactions with the ECs and in vivo biologi-
leukocyte emigration is underscored by the decreasedcal activity. IL-8(1±63) was injected into human skin, and
proemigratory activity of IL-8(1±63) in comparison withits binding and transport by the ECs was compared
native IL-8 (Figures 6A and 6B). This parallels the re-using IEM to that of native IL-8 (Table 2). Initially, the
duced potency of IL-8(1±63) observed in in vitro neutro-amount of IL-8(1±63) that bound to the abluminal EC
phil migration assay (Figure 6C) and contrasts the similarsurface was not significantly different from that of IL-8.
potencies of the two chemokines for neutrophil enzymeHowever, later, the levels of both abluminal and intracel-
release (Figure 6D), which is not dependent on IL-8 im-lular, vesicle-associated IL-8(1±63) were significantly
mobilization. The decreased in vivo and in vitro migra-lower than those of IL-8. The amount of IL-8 on the
tory activities of IL-8(1±63) directly correspond to itsluminal surface increased with time; in contrast, IL-8(1±
reduced (in comparison with IL-8) binding to HS (Figure63) at all the time points was barely detectable on the
6E) and polycarbonate filter (Figure 6F), respectively.luminal cell surface (Table 2). Thus, EC endocytosis of
Thus, similarly to IL-8-induced in vitro leukocyte migra-IL-8 is not happening by nonspecific fluid uptake via
tion, which happens in response to surface-bound
chemokine molecules by haptotactic mechanism (Rot,
1993a), in vivo leukocyte emigration also requires che-
mokine immobilization by the ECs. Furthermore, these
data also suggest that our morphological observations
of the subcellular IL-8 interactions in venular ECs reflect
functionally relevant processes.
Cultured ECs Do Not Bind IL-8
For studying the EC binding and endocytosis of IL-8,
we had to rely completely on the in situ methods: all of
the in vitro-propagated ECs tested by us, including
those derived from skin microvasculature and umbilical
veins, failed, in agreementwith previous reports (Watson
et al., 1995; Petzelbauer et al., 1995), to show specific
IL-8 binding (E. H. and A. R., unpublished data). In con-
trast to microvascular ECs, which rapidly lose their IL-8-
binding ability in the process of culture, ECs in intact
umbilical veins do not bind IL-8 in situ (data not shown).
These findings emphasize the heterogeneous nature of
ECs in different organs and segments of the vascular
tree and caution that the results of the studies that use
cultured ECs to investigate their interaction with chemo-
Figure 4. Reduction of the EC-Associated IL-8 Immunoreactivity by
kines may not faithfully reflect the in vivo situation. MostHeparitinase Treatment
in vitro experimental systems that model chemokine-
Heparitinase treatment (A) diminished IL-8 immunoreactivity in ven-
induced leukocyte-EC adhesion fail to account for theular ECs but not resident dermal cells (arrowed) in comparison with
fact that in vivo leukocytes encounter chemokines inthe chondroitinase-treated section (B) or buffer-treated control (not
shown; [A] and [B], 3781). complex with presentation molecules. The inability of
EC Transcytosis and Presentation of IL-8
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Figure 5. EC Transcytosis of RANTES
EC uptake of RANTES at the abluminal EC membrane (A); RANTES in plasmalemmal vesicles in apical and basal portions of EC cytoplasm
([B] and [C], respectively) and on the tip of luminal projection (D). Lack of EC-associated MIP-1a immunoreactivity following its injection in
human skin ([E]; asterisk marks the lumen; inset shows a detail of an MIP-1a-positive macrophage. (F) RANTES EMA; vertical arrow, horizontal
arrows, and arrowhead show abluminal, intracellular, and luminal radiolabel, respectively; inset shows detail of an intracellular label.
([A]±[C], 398,900; [D], 377,400; [E], 354,040; inset, 343,000; [F], 327,520; inset, 343,000).
Experimental Proceduresthe cultured ECs to couple chemokines with presenta-
tion molecules and display them on microvilli may ex-
Intradermal Chemokine Injections in Rabbitsplain why theEC adhesion of lymphocytes isnot induced
For IEM, human recombinant IL-8 (Novartis Forschungsinstitut [NFI],
efficiently by chemokines in vitro (Butcher and Picker, Vienna, Austria) was injected intradermally, 1 mg/site, in three Chin-
1996). The association with EC presentation molecules, chilla rabbits (Charles River, Wiga, Germany); duplicate biopsies of
the sites were taken 4 hr, 2 hr, 1 hr, 1/2 hr, and immediately afterHS in particular, may increase the chemotactic efficacy
the injection (0 hr). Vehicle-injected sites sampled at the same timeof chemokines (Webb et al., 1993).
points and noninjected skin served as controls. For EMA, ChinchillaIn conclusion, we describe two novel subcellular
rabbits received 5 ng/site of either human recombinant 125I-IL-8 ormechanisms of IL-8 interaction with postcapillary venu- 125I-RANTES (DuPontNEN, Vienna; specific radioactivity 250 mCi/mg)
lar ECs in the process of leukocyte emigration:EC trans- injected into eight intradermal sites. Duplicate sites were punch-
cytosis of chemokine and its luminal surface presen- biopsied at 4 hr, 2 hr, 1 hr, and 1/2 hr after the injection. Vehicle-
injected sites sampled at the same time points and noninjected skintation to the adherent leukocytes on the tips of EC
served as controls.microvilli. We show that IL-8 immobilization via its C
terminus is required for the induction of neutrophil emi-
gration and postulate the cooperative involvement of Ex Vivo Chemokine Injections in Human Skin
HS and DARC in mediating chemokine interaction with Pieces of normal human skin were obtained after informed consent
from four healthy patients undergoing elective surgery. Immediatelythe ECs.
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upon removal, 100 ng/site of IL-8, IL-8 (1±63), RANTES, or MIP-1a
(Peprotech, London, England) was injected into multiple sites and
skin was incubated at room temperature in a RPMI1640 bath. Dupli-
cate sites were cut out and processed for IEM 2 hr, 1 hr, 1/2 hr,
and immediately after the injection (0 hr). Vehicle-injected skin sam-
ples and uninjected skin served as controls. For the enzyme diges-
tion studies, the IL-8-injected human skin was snap-frozen 2 hr after
the injection.
IEM
A modification of the published procedure (Fina et al., 1990) was
used. Samples were fixed for 60 min in 2% paraformaldehyde with
0.05% glutaraldehyde in PBS, washed and dehydrated in gradually
increasing concentrations of ethanol (30%, 50%, 70%, and 100%)
at simultaneously decreasingtemperatures (08C, 2158C, 2308C, and
2508C), and infiltrated at -508C with Lowicryl HM 20 (Agar Scientific,
Stansted, UK ) by gradually increasing its concentration (25%, 50%,
and 75% for 60 min, 100% overnight). The blocks were polymerized
underultraviolet light for at least 48 hr at2508C. Dehydration, infiltra-
tion, andpolymerization were performed in Leica AFS (Leica,Vienna,
Austria). Sections 100 nm thick were cut and collected on uncoated
nickel grids that were placed in blocking buffer (PBS, 5% FCS, 0.8%
BSA, 0.1% fish gelatin [pH 7.4]) for 30 min and then immersed
overnight in anti-IL-8 mouse monoclonal or rabbit polyclonal anti-
bodies (NFI). After repeated washes, sections were incubated for
90 min in 5 or 10 nm gold-labeled goat anti-mouse IgG (Amersham,
Bucks or Biocell, Cardiff, both UK) and 5 nm gold-labeled goat anti-
rabbit IgG (Amersham), respectively. Grids were washed and 5 nm
gold conjugates were silver-enhanced in IntenSE (Amersham), fol-
lowed by washing in ultrapure water. Sections were counterstained
in uranyl acetate and lead citrate, and viewed in a Zeiss EM 10
transmission electron microscope at 80 kV. Control sections were
incubated with purified mouse IgG instead of primary antibody.
Subcellular localization of MIP-1a and RANTES was performed as
described above using mouse monoclonal antibodies (Peprotech
and a generous gift from Pete Nelson, respectively).
EMA
The tissue was processed conventionally for transmission electron
Figure 6. In Vivo and In Vitro Activities of IL-8 and IL-8(1±63) microscopy (EM). It was fixed in 2.5% glutaraldehyde, post-fixed in
(A) Chemokine-induced neutrophil emigration in mice. Balb/C mice osmium tetroxide, block-stained in uranyl acetate, dehydrated in
received intraperitoneal injections of IL-8 and IL-8(1±63). After 3 hr, ethanol, treated with propylene oxide, and embedded in Araldite.
the peritoneal cavities were lavaged and leukocytes counted. Values Ultrathin sections were coated with Ilford L-4 emulsion, exposed
are the mean 6 SEM of three experiments. No neutrophils emigrated for 3±11 weeks, and developed in D-19 as described (Williams,
following vehicle injection. 1978).
(B) Chemokine-induced neutrophil emigration in primate skin. Two
rhesus monkeys (Macacca mulata) received intradermal injections The Subcellular EC Localization of IL-8 and IL-8(1±63)
of IL-8 and IL-8(1±63) into triplicate sites. After 4 hr, the injection in Human Skin
sites were punched out and homogenized, and the myeloperoxidase Both chemokines were injected in human skin and detected by IEM
(MPO) activity was determined. The mean 6 SEM in triplicate injec- using the procedures described above and rabbit polyclonal anti-
tion sites in one monkey are shown; MPO in vehicle-injected sites IL-8 antibody that recognized both IL-8 and IL-8(1±63). For both
was 0.06 6 0.03 U. chemokines, theresulting goldgranules were counted on the luminal
(C) Chemokine-induced in vitro neutrophil migration. Human neutro- and abluminal surfaces and in the cytoplasmic vesicles of the ECs
phils were isolated and their migration was tested in Boyden-type from sixteen randomly chosen postcapillary venules in skin from
chambers. One of three experiments performed on cells from differ- two different individuals. Results were expressed as the number of
ent donors is shown. Values are mean for duplicate wells; error bars
show SD.
(D). Chemokine-induced in vitro release of elastase from human
neutrophils was recorded by monitoring the hydrolysis of an elas-
tase-specific substrate. The values are the mean 6 SEM of determi- (FRET) from tryptophan 57 or by direct excitation and emission of
nations on neutrophils from three different donors. Vehicle induced bis-ANS. These were consistent with respective dissociation con-
the release of 0.9 6 0.02 U of elastase. stants (Kd) of 8.0 6 2.8 mM and 8.9 6 3.3 mM. The same IL-8(1±63),
(E) Binding of chemokines to polycarbonate filter. The amount of bis-ANS, and HS stoichiometry revealed differences between the
chemokines IL-8 and IL-8(1±63) that bound to the nucleopore filter apparent Kds obtained by FRET (24.3 6 8 mM), and direct bis-ANS
during 20 min incubation was assessed using rabbit anti-human fluorescence (118.7 6 66 mM). This difference can be due to (a)
IL-8 antibodies. The values for IL-8(1±63) were multiplied by the considerablechange inthe relative position of the tryptophan's indol
detection correction factor of 1.23. fluorophore due to restructuring of C-terminal a helix of IL-8(1±63)
(F) Binding of HS to IL-8 and IL-8(1±63). A novel fluorescence assay or (b) binding of bis-ANS at different positions within IL-8(1±63). In
allowed the quantitation of HS binding to IL-8 and IL-8(1±63) without conclusion, IL-8(1±63) showed 3- to 14-fold lower affinity for HS
labeling of the chemokines or HS. Dissociation of complexes be- than IL-8.
tween 1 mM IL-8 and 6 mM bis-ANS was induced by increasing Circle, IL-8; triangle, IL-8(1±63); square, HBSS control; on (F), solid
concentrations of HS. The resulting reduction in bis-ANS intensity symbols, excitation 392 nm; empty symbols, 2284 nm. Abscissa
was detected either via fluorescence resonance energy transfer on (A)±(E), chemokine concentration, and on (F), HS concentration.
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gold particles per unit surface length or per unit area of the cyto- amount of elastase released was measured; it was proportionate
to the hydrolysis of nonfluorescent substrate that resulted in a fluo-plasm. Sections of the uninjected sites had been processed and
counted identically. The loss of antigenicity resulting from truncation rescent product, the amount of which was measured on a Fluoro-
scan II (Flow Laboratories, Irvine, Scotland) equipped with 335 nmof nine amino acids in IL-8(1±63) was quantified by drying equal
amounts of both chemokines onto formvar-carbon-coated gridsand excitation interference filter and 460 nm emission filter. Each experi-
ment was performed on neutrophils from three donors.processing them as for IEM. The gold particles were counted in 15
380,000 fields. The mean 6 SEM of 47.4 6 3.6 and 38.5 6 5.3
gold particles for IL-8 and IL-8(1±63), respectively, resulted in the Binding of Chemokines to Polycarbonate Filter
detection correction factor of 1.23 by which all of the values for IL- The amount of IL-8 and IL-8(1±63) that bound to the nucleopore
8(1±63) were multiplied. filter during a 20 min incubation at 378C was assessed using a rabbit-
anti-human IL-8 antibody exactly as described before (Rot, 1993a).
Colocalization of IL-8 and Caveolin The values for IL-8(1±63) were multiplied by the detection correction
Thin sections of ex vivo IL-8-injected human skin were incubated factor of 1.23.
with monoclonal mouse anti-human IL-8 and polyclonal rabbit anti-
caveolin antibodies (Transduction Laboratories, Lexington, KY) that Binding of HS to IL-8 and IL-8(1±63)
were detected with goat anti-mouse 10 nm gold-labeled and goat The affinity of chemokine binding to HS was estimated based on
anti-rabbit 5 nm gold-labeled secondary antibodies, respectively, the ability of HS to inhibit the hydrophobic interaction of 1,19-bi(4-
as described above. anilino)naphtalene-5,59-disulfonic acid (bis-ANS; Rosen and Weber,
1969) with IL-8 and IL-8(1±63). Chemokine (1 mM) in PBS was incu-
Susceptibility of EC Localization of IL-8 to Hydrolytic Digestion bated for 30 min with 6 mM bis-ANS in 0.06% DMSO and was then
Frozen sections (10 mm) of ex vivo IL-8-injected human skin were competed off by HS. Steady-state fluorescence measurements were
acetone-fixed for 10 min and incubated for 30 min at 378C in either performed on a SLM 8000C spectro-fluorometer equipped with JD-
TRIS (pH 7.5), chondroitinase ABC, or heparitinase (both 50 U/ml; 490 photomultipliers and a 450 W Xenon Arclamp (SLM Instruments,
Seikagaku, Tokyo, Japan). Following the treatment, the slides were Urbana, IL) at 258C in a 1000 Tl quartz cuvette (10 mm optical
washed extensively in TRIS and incubated with mouse monoclonal pathlength). Spectral bandwidths were set to 8 and 16 nm for excita-
anti-IL-8 antibody (Novartis Forschungsinstitut), binding of which tion and emission, respectively. The relative reduction in bis-ANS
was detected using APAAP kit (Dako, Glostrup, Denmark). The slides fluorescence intensity was detected either via fluorescence reso-
were studied under an Olympus BX60 microscope. nance energy transfer (FRET) from tryptophan 57 in IL-8 or IL-8(1±63)
or by direct excitation and emission of bis-ANS in magic angle
Chemokine-Induced Neutrophil Emigration in Mice setting with the excitation wavelengths set to 284 nm and 392 nm,
Balb/C mice (Charles River) received intraperitoneal injections of respectively. The data were corrected for primary inner filter effects
IL-8, IL-8(1±63), or vehicle control. After 3 hr, the peritoneal cavities using an empirical exponential equation (Birdsall et al., 1983). The
were lavaged and total and differential counts of leukocytes in the fluorescence emission intensity of bis-ANS was integrated between
lavage fluid were performed. The response to each tested concen- 420 nm and 600 nm. The spectra were corrected for Raman scatter-
tration of chemokines was determined in three animals. ing from the buffer solution, for IL-8±bis-ANS complex fluorescence,
for a small fluorescence enhancement of bis-ANS interaction with
Chemokine-Induced Neutrophil Emigration HS, and for fluorescence of the HS (Sigma-Aldrich). For each HS
in Primate Skin concentration, the spectra were averaged over three recordings
Two rhesus monkeys (Macacca mulata) received intradermal injec- with an integration time of 2 sec and a step resolution of 2 nm. The
tions of IL-8 , IL-8(1±63), and vehicle control into triplicate sites. reduction of the integrated fluorescence intensity of the chemokine
After 4 hr, the injection sites were punch-biopsied, snap-frozen, bis-ANS was plotted as a function of the HS concentration (average
and homogenized in a 50 mM potassium phosphate buffer (3 ml) molecular weight of 20,000 g/Mol) and fit to the equation F 5 Fmin 1
containing 0.5% hexadecyltrimethylammoniumbromide (HTAB; ((Fmax 2 Fmin) * (([IL-8] 1 [HS] 1 Kd) 2 (([IL-8] 1 [HS] 1 Kd)2 2
Sigma-Aldrich, Austria) at a pH of 6.0. Samples were sonicated and 4*[IL-8]*[HS])1/2)) / 2 * [IL-8], to result in apparent dissociation con-
snap-frozen three times before pelleting at 10,000 3 g. Myeloperoxi- stants for chemokine interactions with HS.
dase (MPO), representative of neutrophil numbers, was assayed by
adapting the described procedure (Bradley et al., 1992). In a 96-well In Situ Binding Assay
plate samples or MPO standard (stored as a stock solution of 5 Normal human umbilical cords were obtained after informed consent
U/mg protein at 2808C; Sigma-Aldrich) were diluted in a potassium and immediately cut into 2 mm slices with a scalpel blade. The in
phosphate buffer containing 0.5% HTAB at a pH of 5.4, so that each situ binding of 125I-IL-8 (DuPont) to intact cord pieces was evaluated
well contained 100 ml. The reaction was started by the addition of as described previously (Rot, 1992b).
80 ml of tetramethylbenzidine substrate and hydrogen peroxide as
a ready-to-use liquid (Sigma-Aldrich). Plates were incubated for 10 Acknowledgments
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Chemokine-Induced Neutrophil Elastase Release
Chemokine-induced in vitro release of elastase from human neutro-
Referencesphils was measured essentially as previously described (Dewald
and Baggiolini, 1987). Briefly, 106 neutrophils were resuspended in
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related chemotactic cytokinesÐCXC and CC chemokines. Adv. Im-the cells were incubated in a microtiter plate for 15 min at 378C.
munol. 55, 97±197.The elastase secretion was initiated by adding different concentra-
tions of IL-8 and IL-8(1±63) and a buffer control. After 30 min, the Berlin, C., Bargatze, R.F., Campbell, J.J., von Andrian, U.H., Szabo,
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